MMDA-3a
Pharmaceutical compound
From Wikipedia, the free encyclopedia
MMDA-3a, also known as 2-methoxy-3,4-methylenedioxyamphetamine or as 2-methoxy-MDA, is a psychedelic drug of the amphetamine family.[1][2] It is the 2-methoxy derivative of 3,4-methylenedioxyamphetamine (MDA).[1] The drug produces hallucinogenic effects in humans.[1] Its dose is listed as 20 to 80 mg orally and its duration as 10 to 16 hours in Alexander Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved).[1][2] A higher dose of 100 mg was also reportedly explored and doses of 80 to 100 mg were said to be very similar to 100 μg LSD.[1] The chemical synthesis of MMDA-3a has been described.[1][2] MMDA-3a is a positional isomer of MMDA and hence is a Schedule I controlled substance in the United States.[2] It is also a controlled substance in Canada under phenethylamine blanket-ban language.[3]
- None
| Clinical data | |
|---|---|
| Other names | 2-Methoxy-3,4-methylenedioxyamphetamine; 2-Methoxy-MDA; 2-MeO-MDA |
| Routes of administration | Oral[1][2] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 10–16 hours[1][2] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H15NO3 |
| Molar mass | 209.245 g·mol−1 |
| 3D model (JSmol) | |
| |
| |